Patents by Inventor Timothy J. SOOS

Timothy J. SOOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extracellular vesicles for vaccine delivery
    Patent number: 11992527
    Abstract: The present disclosure relates to extracellular vesicles (EVs), e.g., exosomes, comprising a payload (e.g., an antigen, adjuvant, and/or immune modulator) and/or a targeting moiety. Also provided herein are methods for producing the EVs (e.g., exosomes) and methods for using the EVs (e.g., exosomes) to treat and/or prevent diseases or disorders, e.g., cancer, graft-versus-host disease (GvHD), autoimmune disease, infectious diseases, or fibrotic diseases.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: May 28, 2024
    Assignee: LONZA SALES AG
    Inventors: Raymond J. Moniz, Russell E. McConnell, Nikki Ross, Christine McCoy, Timothy J. Soos, Ke Xu
  • EXTRACELLULAR VESICLES FOR VACCINE DELIVERY
    Publication number: 20230263885
    Abstract: The present disclosure relates to extracellular vesicles (EVs), e.g., exosomes, comprising a payload (e.g., an antigen, adjuvant, and/or immune modulator) and/or a targeting moiety. Also provided herein are methods for producing the EVs (e.g., exosomes) and methods for using the EVs (e.g., exosomes) to treat and/or prevent diseases or disorders, e.g., cancer, graft-versus-host disease (GvHD), autoimmune disease, infectious diseases, or fibrotic diseases.
    Type: Application
    Filed: October 26, 2022
    Publication date: August 24, 2023
    Applicant: Codiak BioSciences, Inc.
    Inventors: Raymond J. MONIZ, Russell E. MCCONNELL, Nikki ROSS, Christine MCCOY, Timothy J. SOOS, Ke XU
  • EXTRACELLULAR VESICLES FOR VACCINE DELIVERY
    Publication number: 20220168415
    Abstract: The present disclosure relates to extracellular vesicles (EVs), e.g., exosomes, comprising a payload (e.g., an antigen, adjuvant, and/or immune modulator) and/or a targeting moiety. Also provided herein are methods for producing the EVs (e.g., exosomes) and methods for using the EVs (e.g., exosomes) to treat and/or prevent diseases or disorders, e.g., cancer, graft-versus-host disease (GvHD), autoimmune disease, infectious diseases, or fibrotic diseases.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 2, 2022
    Applicant: Codiak BioSciences, Inc.
    Inventors: Raymond J. MONIZ, Russell E. MCCONNELL, Nikki ROSS, Christine MCCOY, Timothy J. SOOS, Ke XU